New Eye Drops , May Help People , With Age-Related Vision Problems.
'The New York Times' reports that a new prescription
eye-drop that improves close-range vision could help
many people with age-related vision problems. .
Allergen's Vuity treats age-related
vision loss, a condition called presbyopia. .
According to 'The New York Times,' about 90% of adults over 45 in the U.S. suffer from presbyopia. .
Dr. George O. Waring IV, the medical
director of the Waring Vision Institute,
led Allergan's clinical trials for Vuity.
The results of the drug's Phase 3 clinical trials have not been published in a peer-reviewed journal. .
In October, the drug was approved by
the U.S. Food and Drug Administration.
Dr. Waring said that most
health and vision insurance won't cover Vuity. .
A 30-day supply costs about $80. .
Dr. Scott M. MacRae, an ophthalmologist at the University
of Rochester’s Center for Visual Science, said that Vuity
will work best for people with mild to moderate presbyopia. .
'The New York Times' notes that Vuity does not work for nearsightedness, farsightedness or astigmatism. .
Pilocarpine, the active ingredient
of Vuity, has reportedly been used
to treat glaucoma for decades